46 related articles for article (PubMed ID: 21355774)
1. Feasibility of outpatient daycase local anaesthestic Rezūm™ without sedation.
Khadhouri S; Guillaumier S; Drummond L; Dreyer B; Clelland C; Jaafari FA
BMC Urol; 2024 Apr; 24(1):80. PubMed ID: 38575918
[TBL] [Abstract][Full Text] [Related]
2. Scalpel-free surgery could reduce surgeons' risk of HIV and hepatitis.
Labib M
Med J Zambia; 2010; 37(2):99-103. PubMed ID: 23457420
[TBL] [Abstract][Full Text] [Related]
3. MR-Guided Transurethral Ultrasound Ablation (TULSA): An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.
Akhlaghpour S
Cardiovasc Intervent Radiol; 2024 Jun; 47(6):702-704. PubMed ID: 38710796
[No Abstract] [Full Text] [Related]
4. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.
Pacella CM; Patelli G; Iapicca G; Manenti G; Perretta T; Ryan CP; Esposito R; Mauri G
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):356-363. PubMed ID: 31827239
[TBL] [Abstract][Full Text] [Related]
5. Mechanochemical Disruption Suppresses Metastatic Phenotype and Pushes Prostate Cancer Cells toward Apoptosis.
Murad HY; Yu H; Luo D; Bortz EP; Halliburton GM; Sholl AB; Khismatullin DB
Mol Cancer Res; 2019 May; 17(5):1087-1101. PubMed ID: 30617107
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies.
Christidis D; McGrath S; Perera M; Manning T; Bolton D; Lawrentschuk N
Prostate Int; 2017 Jun; 5(2):41-46. PubMed ID: 28593165
[TBL] [Abstract][Full Text] [Related]
7. New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives.
Albisinni S; Biaou I; Marcelis Q; Aoun F; De Nunzio C; Roumeguère T
BMC Urol; 2016 Sep; 16(1):58. PubMed ID: 27629059
[TBL] [Abstract][Full Text] [Related]
8. Holmium Laser Enucleation of the Prostate is Safe for Patients Above 80 Years: A Prospective Study.
Piao S; Choo MS; Kim M; Jeon HJ; Oh SJ
Int Neurourol J; 2016 Jun; 20(2):143-50. PubMed ID: 27377947
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update.
Aoun F; Marcelis Q; Roumeguère T
Res Rep Urol; 2015; 7():125-36. PubMed ID: 26317083
[TBL] [Abstract][Full Text] [Related]
10. Surgical therapy for benign prostatic hypertrophy/bladder outflow obstruction.
Thiruchelvam N
Indian J Urol; 2014 Apr; 30(2):202-7. PubMed ID: 24744521
[TBL] [Abstract][Full Text] [Related]
11. Primary results of transurethral prostate ethanol injection.
Arslan M; Oztürk A; Goger YE; Aslan E; Kilinc M
Int Urol Nephrol; 2014 Sep; 46(9):1709-13. PubMed ID: 24705726
[TBL] [Abstract][Full Text] [Related]
12. [Intraprostatic injection therapy in patients with benign prostatic syndrome].
Bschleipfer T; Bach T; Gratzke C; Madersbacher S; Oelke M
Urologe A; 2013 Mar; 52(3):354-8. PubMed ID: 23435646
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
[TBL] [Abstract][Full Text] [Related]
15. Transurethral ethanol ablation of the prostate (TEAP): an effective minimally invasive treatment alternative to traditional surgery for symptomatic benign prostatic hyperplasia (BPH) in high-risk comorbidity patients.
Magno C; Mucciardi G; Galì A; Anastasi G; Inferrera A; Morgia G
Int Urol Nephrol; 2008; 40(4):941-6. PubMed ID: 18478352
[TBL] [Abstract][Full Text] [Related]
16. Transurethral needle ablation of the prostate: a minimally invasive treatment for symptomatic benign prostatic hyperplasia.
Beduschi MC; Oesterling JE
Mayo Clin Proc; 1998 Jul; 73(7):696-701. PubMed ID: 9663202
[TBL] [Abstract][Full Text] [Related]
17. Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man.
Rukstalis DB
Can J Urol; 2015 Oct; 22 Suppl 1():67-74. PubMed ID: 26497346
[TBL] [Abstract][Full Text] [Related]
18. Transurethral ethanol ablation of the prostate for symptomatic benign prostatic hyperplasia: long-term follow-up.
El-Husseiny T; Buchholz N
J Endourol; 2011 Mar; 25(3):477-80. PubMed ID: 21355774
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
